In a move expected to increase competition and lower drug prices, the Food and Drug Administration today approved the first “biosimilar” drug, designed to closely mimic existing drugs grown in living cells. Pharmaceutical companies have been able to produce low-cost generic drugs for three decades, but they haven’t before been able to produce knockoff versions […]

Victory! CDC’s Advisory Committee for Immunization Practices (ACIP) voted unanimously to recommend the Meningitis B vaccine for at risk populations. In June, the panel will evaluate broader recommendation for college students. Seth had the honor of reading the comments prepared by Neal Raisman, who unfortunately had to return home to Columbus, and was not able […]

Listen to Representative Dee (bill sponsor) highlight the power and importance of the patient perspective in his final comments here           Click Here to listen to the interview on Healthy Biologics Transcript: “I did not ask for, nor did I know, that the witness Tabatha Yager would be here today. But I […]

Good afternoon. My name is Mariah Leach. I want to thank the Colorado Senate Health & Human Services Committee for allowing me to speak today. I live in Louisville, CO and I was diagnosed with rheumatoid arthritis six years ago.

Clearly, there is a real need to ensure the safe and warranted use of prescription pain medications. Yet while regulators debate access restrictions, a part of the conversation that remains unheard is what access limitations mean for patients very much in need of appropriately prescribed medications.

Much cheaper, life-saving drugs could become available this year. They are called biosimilars and are copycat versions of drugs for diseases like rheumatoid arthritis, breast cancer and psoriasis….

There’s an issue quietly taking place in state legislatures all across the country. You may not have heard much about it – but if you are a patient living with rheumatoid arthritis it is an issue that will be very likely to affect you in the not too distant future.